AC
Alexandra Cantley
Partner at Polaris Partners
New York, New York
Overview
Alexandra Cantley is a Partner at Polaris Partners in New York City, with a background in high throughput screening, organic synthesis, and chemical biology. She has invested in notable companies like EpiBiologics and Auron Therapeutics at Series A stages, showcasing her expertise in the digital health and biotech sectors.
Work Experience
Partner
2021 - Current
Principal
2019
Polaris Partners is an investment firm that invests in healthcare and biotechnology companies.
Scientist
2017 - 2019
Vertex Fellow
2016 - 2017
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
Raised $657,308,360.00 from J.P. Morgan Securities Inc., Bank of America Merrill Lynch, Morgan Stanley, Goldman Sachs and Janssen Belgium.
Graduate Student
2011 - 2016
Clardy Lab Discovery, isolation and synthesis of natural products that mediate symbiotic interactions between microorganisms.
Research technician
2009 - 2011
Stockwell Lab High throughput screening, cancer research
Education
Doctor of Philosophy (PhD)
2011 - 2016
Bachelor of Arts (B.A.)
2005 - 2009